Sabriya A. Syed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sabriya A. Syed has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Tamas Ordog
Mayo Clinic
10 shared publications - Yujiro Hayashi
Enteric Neuroscience Program and Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA; Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA
8 shared publications Gabriella B. Gajdos
Mayo Clinic
6 shared publications- Gianrico Farrugia
Mayo Clinic Rochester Minnesota USA
5 shared publications - Huihuang Yan
Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, USA
5 shared publications - Jeong-Heon Lee
Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
5 shared publications
Latest Publications
- Open Access
Calcineurin broadly regulates the initiation of skeletal muscle-specific gene expression by binding target promoters and facilitating the interaction of the SWI/SNF chromatin remodeling enzyme
Calcineurin (Cn) is a calcium-activated serine/threonine protein phosphatase that is broadly implicated in diverse cellular processes, including the regulation of gene expression. During skeletal muscle differentiation, Cn activates the NFAT transcription factor but also promotes differentiation by counteracting the negative influences of protein kinase C beta (PKCβ) via dephosphorylation and activation of BRG1, an enzymatic subunit of the mammalian SWI/SNF ATP-dependent chromatin remodeling enzyme. Here we identified four major temporal patterns of Cn-dependent gene expression in differentiating myoblasts and determined that Cn is broadly required for the activation of the myogenic gene expression program. Mechanistically, Cn promotes gene expression through direct binding to myogenic promoter sequences and facilitating the binding of BRG1, other SWI/SNF subunit proteins, and MyoD, a critical lineage determinant for skeletal muscle differentiation. We conclude that the Cn phosphatase directly impacts the expression of myogenic genes by promoting ATP-dependent chromatin remodeling and formation of transcription-competent promoters.
Open AccessCalcineurin broadly regulates the initiation of skeletal muscle-specific gene expression by binding target promoters and facilitating the interaction of the SWI/SNF chromatin remodeling enzyme
Calcineurin (Cn) is a calcium-activated serine/threonine protein phosphatase that is broadly implicated in diverse cellular processes, including the regulation of gene expression. During skeletal muscle differentiation, Cn activates the NFAT transcription factor but also promotes differentiation by counteracting the negative influences of protein kinase C beta (PKCβ) via dephosphorylation and activation of BRG1, an enzymatic subunit of the mammalian SWI/SNF ATP-dependent chromatin remodeling enzyme. Here we identified four major temporal patterns of Cn-dependent gene expression in differentiating myoblasts and determined that Cn is broadly required for the activation of the myogenic gene expression program. Mechanistically, Cn promotes gene expression through direct binding to myogenic promoter sequences and facilitating the binding of BRG1, other SWI/SNF subunit proteins, and MyoD, a critical lineage determinant for skeletal muscle differentiation. We conclude that the Cn phosphatase directly impacts the expression of myogenic genes by promoting ATP-dependent chromatin remodeling and formation of transcription-competent promoters.
- Open Access
Ezh2-dependent epigenetic reprogramming controls a developmental switch between modes of gastric neuromuscular regulation
SUMMARY: Physiological interconversion between specialized cell types has only been described in a few mammalian tissues and the mechanisms remain obscure. Using genetic lineage tracing during postnatal development and in-vitro models we demonstrate conversion of gastric interstitial cells of Cajal (ICC), regulatory cells that electrically pace phasic contractions and mediate nitrergic and cholinergic neural control of smooth muscle cells, into phenotypically distinct “fibroblast-like” interstitial cells (FLC), which only mediate purinergic signaling. Mechanistically, we find this transition to be epigenetically governed by H3K27 trimethylation of cell identity-related promoters whose susceptibility to repression is predicted by H3K27 acetylation patterns in ICC. The phenotypic switch was reversible by inhibition, knockdown or in-vivo genomic inactivation of the polycomb H3K27 methyl-transferase Ezh2. These results demonstrate a role for Ezh2-mediated epigenetic repression in physiological mammalian transdifferentiation and identify FLC as a reserve from which ICC can potentially be restored in common gastrointestinal disorders where ICC are depleted. GRAPHICAL HIGHLIGHTS: Gastric pacemaker cells (ICC) transdifferentiate into quiescent cells (FLC) in vivo ICC-to-FLC shift switches neural control from nitrergic/cholinergic to purinergic Ezh2-mediated H3K27me3 represses cell-identity genes during ICC-to-FLC transition Ezh2 inhibition restores ICC numbers, phenotype and function eTOC BLURB: Syed et al. find aging to cause transdifferentiation of gastric pacemaker cells (interstitial cells of Cajal, ICC), which also communicate cholinergic and nitrergic neurotransmission to smooth muscle cells, into quiescent “fibroblast-like cells” (FLC), which only mediate purinergic signals. This switch is governed by Ezh2, whose inhibition can reverse ICC depletion.
Open AccessEzh2-dependent epigenetic reprogramming controls a developmental switch between modes of gastric neuromuscular regulation
SUMMARY: Physiological interconversion between specialized cell types has only been described in a few mammalian tissues and the mechanisms remain obscure. Using genetic lineage tracing during postnatal development and in-vitro models we demonstrate conversion of gastric interstitial cells of Cajal (ICC), regulatory cells that electrically pace phasic contractions and mediate nitrergic and cholinergic neural control of smooth muscle cells, into phenotypically distinct “fibroblast-like” interstitial cells (FLC), which only mediate purinergic signaling. Mechanistically, we find this transition to be epigenetically governed by H3K27 trimethylation of cell identity-related promoters whose susceptibility to repression is predicted by H3K27 acetylation patterns in ICC. The phenotypic switch was reversible by inhibition, knockdown or in-vivo genomic inactivation of the polycomb H3K27 methyl-transferase Ezh2. These results demonstrate a role for Ezh2-mediated epigenetic repression in physiological mammalian transdifferentiation and identify FLC as a reserve from which ICC can potentially be restored in common gastrointestinal disorders where ICC are depleted. GRAPHICAL HIGHLIGHTS: Gastric pacemaker cells (ICC) transdifferentiate into quiescent cells (FLC) in vivo ICC-to-FLC shift switches neural control from nitrergic/cholinergic to purinergic Ezh2-mediated H3K27me3 represses cell-identity genes during ICC-to-FLC transition Ezh2 inhibition restores ICC numbers, phenotype and function eTOC BLURB: Syed et al. find aging to cause transdifferentiation of gastric pacemaker cells (interstitial cells of Cajal, ICC), which also communicate cholinergic and nitrergic neurotransmission to smooth muscle cells, into quiescent “fibroblast-like cells” (FLC), which only mediate purinergic signals. This switch is governed by Ezh2, whose inhibition can reverse ICC depletion.
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
743 - Physiological Effects of Regulation of ANO1 Transcription by Gli in Mouse Interstitial Cells of Cajal
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
743 - Physiological Effects of Regulation of ANO1 Transcription by Gli in Mouse Interstitial Cells of Cajal
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S565-S566
Hypoxia-Inducible Factor 1 Alpha (HIF1A) Stimulates Neuronal Nitric Oxide Synthase (NOS1) Transcription by Binding to Multiple Enhancers
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S565-S566
Hypoxia-Inducible Factor 1 Alpha (HIF1A) Stimulates Neuronal Nitric Oxide Synthase (NOS1) Transcription by Binding to Multiple Enhancers
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S129-S130
Succinate Accumulation Epigenetically Represses Kit Expression, Reduces Interstitial Cells of Cajal (ICC) and Delays Gastric Emptying of Solids
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S129-S130
Succinate Accumulation Epigenetically Represses Kit Expression, Reduces Interstitial Cells of Cajal (ICC) and Delays Gastric Emptying of Solids
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S31
131 Glucose Oxidative Metabolism Regulates Interstitial Cell of Cajal Populations by Stimulating KIT Expression via ERK MAPK-Dependent ETV1 Stabilization
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S31
131 Glucose Oxidative Metabolism Regulates Interstitial Cell of Cajal Populations by Stimulating KIT Expression via ERK MAPK-Dependent ETV1 Stabilization
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S343-S344
Sa1677 The Polycomb Histone Lysine Methyltransferase EZH2 Controls Interstitial Cell of Cajal Populations by Regulating Stem Cell Differentiation and Self-Renewal
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S343-S344
Sa1677 The Polycomb Histone Lysine Methyltransferase EZH2 Controls Interstitial Cell of Cajal Populations by Regulating Stem Cell Differentiation and Self-Renewal
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S80
339 Hypoxia-Inducible Factor 1 Transactivates Neuronal Nitric Oxide Synthase and Is a Potential Therapeutic Target in Gastroparesis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S80
339 Hypoxia-Inducible Factor 1 Transactivates Neuronal Nitric Oxide Synthase and Is a Potential Therapeutic Target in Gastroparesis